Gradient Denervation Technologies

Gradient aims to enhance the condition of people with pulmonary hypertension.

Total raised

€14M

€14,000,000

Funding rounds

Investors

distinct backers

Active since

2023-09

latest 2023-09

Funding by year

EUR raised per year

High confidence

Raise-next likelihood32

base rate 44% for Series A

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2023-09-08	Series A	€14M	Asabys Partners,Sofinnova Partners,Thuja Capital	View deal →

same sector or country